Navigation Links
Newly identified B-cell selection process adds to understanding of antibody diversity
Date:6/9/2014

e three genes come together, a stretch called the third complementarity-determining region, or CDR3.

"CDR3 is thought to be the single most important determinant of antigen binding," explains Arnaout. As a result, in understanding how the body fights infections and in developing new vaccines, immunologists have primarily focused their attention on CDR3, while considering other parts of the antibody, including the elbow region, to play secondary roles.

In their new study, Arnaout and colleagues sequenced 2.8 million VDJ-recombined heavy-chain genes from immature and mature B-cell subsets in mice. "We initially wanted to ask how selection on CDR3 changed antibody repertoires during B-cell maturation," says Arnaout. But, unexpectedly, during the course of the investigation, they found they were instead focused on the antibody's 'elbow' region."

They found that B cells for which antibodies use V genes that encode 'looser' elbows were more likely to mature, regardless of their CDR3 sequence. This effect was both distinct from, and larger than previously described maturation-associated changes in CDR3 in the mice. Furthermore, it had a unique source: Differences in the V genes were hard-coded into the genome, as opposed to the mixed-and-matched combination of V, D and J genes that typically differs from B cell to B cell.

"This discovery was a little like going to watch a concert pianist perform and being mesmerized by her fingers only to realize that music was also coming from her elbows," says Arnaout. "It was something of a shock."

One explanation for how this "loose elbow" promotes survival relates to the bending process of the antibody. "B-cell selection and maturation depend on signaling," he explains. "Antigen binding is the signal, but for it to get to the cell it has to go through the elbow. It, therefore, makes sense that previous experiments have found that disrupting the elbow abolishes signaling without affecting a
'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Newly identified brain cancer mutation will aid drug development
2. Newly found dinosaur is long-nosed cousin of Tyrannosaurus rex
3. Newly discovered molecule may offer hope for immune disorders and runaway inflammation
4. Newly identified small-RNA pathway defends genome against the enemy within
5. Newly discovered catalyst could lead to the low-cost production of clean methanol
6. Newly discovered marsupial the victim of fatal attraction
7. Newly discovered signaling pathway could impact a variety of autoinflammatory diseases
8. Newly discovered human peptide may become a new treatment for diabetes
9. Attention Vical Incorporated Investors: Vical Misled Investors According to a Newly Filed Class Action
10. Newly identified proteins make promising targets for blocking graft-vs.-host disease
11. UF: Newly discovered tiger shark migration pattern might explain attacks near Hawaii
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/12/2015)... , Feb. 12, 2015   MedNet Solutions ... in clinical study management systems, has recently bolstered ... further distinguishing iMedNet as ... Organizations (CROs) and healthcare consultants.  Building on the ... customer referrals and numerous co-marketing opportunities), MedNet,s new ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... the immune system and thwarting biological defenses. To ... the cancer,s chemical arsenal and boost a patient,s immune ... are rarely successful. Now, researchers have developed a ... both an immune-system booster and a chemical to counter ...
... Policy makers need to be cautious in setting new ... fuels as well as fuels from conventional crude oils ... in a paper published in the journal Environmental ... the first time confidential data from actual oil sands ...
... /PRNewswire-iReach/ -- Golden West Biologicals, Inc. is pleased to announce ... hosted by the American Association for Clinical Chemistry, at the ... 17 to 19. Golden West Biologicals (GWB) has ... products for the development of immunoassays since 1989.  This marks ...
Cached Biology News:Elegant delivery 2Elegant delivery 3Caution needed with new greenhouse gas emission standards 2
(Date:2/26/2015)... The Movement for Indefinite Life Extension ... extension technologies and awareness. The event is taking place ... March 21st 2015, in a live Google Hangout broadcast ... Founder of MILE, says, “Our lives are in our ... for Indefinite Life Extension is raising awareness about bio-sciences ...
(Date:2/26/2015)... IRVINE, Calif. , Feb. 26, 2015 /PRNewswire/ ... of age-defying aesthetic products for skin and hair ... Market Relations as agency of record for investor ... continues to improve our distribution, sales and diversification ... activities to current and prospective shareholders," stated Ali ...
(Date:2/26/2015)... BioEnterprise today announced that Northeast ... $2 billion in growth funding during the past 13 ... sources, state – including the Ohio Third Frontier - ... has been raised in the past five years. ... the BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Already well ... gauging line by expanding its Length Gauge offerings with ... gauges. , Specifically, HEIDENHAIN’s pencil probe-style SPECTO ... force specification. Two new 1Vpp, 12mm stroke length ... force applications. One is a variant with a weak ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2
...  Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced ... and Drug Administration,s (FDA) Oncologic Drugs Advisory Committee (ODAC) ... pixantrone for the treatment of relapsed or refractory aggressive ... more lines of prior therapy. ODAC is a panel ...
... in German . , Even the costliest ... carpet-weavers deliberately include tiny mistakes in their fine carpets, because ... as the nanotechnology industry would like to have them are ... team of physicists headed by Dr. Markus Lackinger from the ...
... Md. and CHERTSEY, England, Dec. 27, 2011  United ... its wholly-owned subsidiary, United Therapeutics Europe, Ltd., announced ... Francaise de Securite Sanitaire des Produits de Sante ... (treprostinil) for the treatment of pulmonary arterial hypertension ...
Cached Biology Technology:FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012 2FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012 3FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012 4The art of molecular carpet-weaving 2Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 2Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 3Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 4Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 5
Alexa Fluor 647 anti-mouse Qa-2...
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
... normalization is essential for hunting and ... approaches, such as EST sequencing projects, ... TRIMMER-DIRECT kit is developed for normalization ... and intended for directional cloning. While ...
... The Luminex 100 Instrument System ... multi-analyte assays using Upstate's Beadlyte reagents. ... the Dell computer with software version ... Sheath Delivery System. Upstate offers $2000 ...
Biology Products: